神经淋巴瘤病的临床表现,管理和结果:系统性审查

Leon D Kaulen1, Thomas Hielscher1, Sofia Doubrovinskaia1

  • 1From the Department of Neurology (L.D.K., S.D., D.C.H., T.K., B.-L.T., W.W.), University Hospital Heidelberg, Heidelberg University; Clinical Cooperation Unit (CCU) Neuro-Oncology (L.D.K., D.C.H., T.K., W.W.), German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research, Heidelberg; Department of Biostatistics (T.H.), German Cancer Research Center (DKFZ), Heidelberg, Germany; and Departments of Neurology and Neurosurgery (J.M.B.), Yale School of Medicine, New Haven, CT.

Neurology
|August 5, 2024
PubMed
概括

神经淋巴瘤 (NL) 是一个具有挑战性的诊断在周围神经系统的淋巴瘤. 在FDG-PET的帮助下,早期识别和基于Rituximab的治疗改善了这种疾病的结果.